DIR 220 - Commercial supply of multivalent cat vaccines containing a genetically modified component for the prevention of feline leukemia virus infection

Page 1 of 5

Closes 2 Jun 2026

This service needs cookies enabled.

Contact Information

1. What is your name?
2. What is your email address?

(we will use this to let you know how your submission was considered in the final RARMP)